Stockwatch: biotech stock propagandists, beware!

In Allan Massie's series of historical novels set in Bordeaux from 1940, the war in Europe is followed through the lives of French civilians as the invasion turns to into the occupation, and collaboration rather than resistance becomes acceptable and even encouraged. After the liberation however, collaboration takes on a quite different connotation.

In Allan Massie's series of historical novels set in Bordeaux from 1940, the war in Europe is followed through the lives of French civilians as the invasion turns to into the occupation, and collaboration rather than resistance becomes acceptable and even encouraged. After the liberation however, collaboration takes on a quite different connotation.

As broad stock market indices stagnate and become range-bound while breath is held before a probable Grexit, a possible Brexit,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Anti-infective

More from Therapy Areas

AbbVie Licenses IGI’s ISB 2001 In Second Myeloma Trispecific Deal For 2025

 

IGI CEO Cyril Konto said in an interview that his company picked AbbVie for its agility, drug development acumen and expertise in areas like intellectual property and legal affairs.

Ultragenyx and Mereo Still Confident Despite Setrusumab Slip Up

 
• By 

The osteogenesis imperfecta drug stumbled in a second interim analysis.

Investors Back Nuclidium’s Next-Gen Copper-Based Radiopharmaceuticals

 

The Swiss company believes its platform can make radiopharmaceuticals easier to produce and more accessible to patients.